BONE BIOLOGICS CORP C/WTS (TO P
BBLGW
Last
$7.70
Day
+60.4%
1y
+63.4%
5y
+449.2%
52w
-93.1%
SPY YTD
+13.3%
Sec
—
Earnings
—
EMA 21
6.79
EMA 50
11.31
EMA 200
16.90
20d high
-35.3%
5y high
-93.1%
5y range
7th
Positions held
Your positionsBBLGW isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-13
Hold
avoid
Signal
Sell
Target
$9.73
Stop
$3.87
Stop distance
49.7%
Target vs last
+26.4%
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | 3.55 | Beta | 0.57 | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -55.0% | ROA | -33.5% | Debt / equity | — |
| Current ratio | 8.67 | Free cash flow | -$1.69M | Analyst recommendation | none | Mean target | — |
| 52w high | $35.95 | 52w low | $3.50 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — | — |
| Net income | -$0.8M | -$0.8M | -$0.7M | -$0.7M | -$0.7M |
| Gross margin | — | — | — | — | — |
| Gross profit | $0.0M | — | — | — | $0.0M |
| Operating income | -$0.8M | -$0.8M | -$0.7M | -$0.7M | -$0.7M |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$3.1M | -$4.1M | -$8.9M | -$1.5M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | $0.0M | $0.0M |
| Operating income | -$3.2M | -$4.2M | -$9.4M | -$3.7M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
No headlines.
Price (daily)
Full chart · RSI · MACD · patternsBBLGW · daily+24.2% over 12 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin